 PITTSBURGH, March 29, 2021 GLOBE NEWSWIRE -- Krystal Biotech Inc., Krystal NASDAQ: KRYS, the leader in redosable gene therapies for rare diseases, today announced participation in two upcoming virtual conferences. 